Title 16

Volume 2 CHAPTER II SUBCHAP E

Subchapter E - Poison Prevention Packaging Act Of 1970 Regulations

16:2.0.1.5.116PART 1700
PART 1700 - POISON PREVENTION PACKAGING
16:2.0.1.5.116.0.2.1SECTION 1700.1
     1700.1 Definitions.
16:2.0.1.5.116.0.2.2SECTION 1700.2
     1700.2 Authority.
16:2.0.1.5.116.0.2.3SECTION 1700.3
     1700.3 Establishment of standards for special packaging.
16:2.0.1.5.116.0.2.4SECTION 1700.4
     1700.4 Effective date of standards.
16:2.0.1.5.116.0.2.5SECTION 1700.5
     1700.5 Noncomplying package requirements.
16:2.0.1.5.116.0.2.6SECTION 1700.14
     1700.14 Substances requiring special packaging.
16:2.0.1.5.116.0.2.7SECTION 1700.15
     1700.15 Poison prevention packaging standards.
16:2.0.1.5.116.0.2.8SECTION 1700.20
     1700.20 Testing procedure for special packaging.
16:2.0.1.5.117PART 1701
PART 1701 - STATEMENTS OF POLICY AND INTERPRETATION
16:2.0.1.5.117.0.2.1SECTION 1701.1
     1701.1 Special packaging for substances subject to a standard that are distributed to pharmacies to be dispensed pursuant to an order of a licensed medical practitioner.
16:2.0.1.5.117.0.2.2SECTION 1701.3
     1701.3 Applicability of special packaging requirements to hazardous substances in large size containers.
16:2.0.1.5.118PART 1702
PART 1702 - PETITIONS FOR EXEMPTIONS FROM POISON PREVENTION PACKAGING ACT REQUIREMENTS; PETITION PROCEDURES AND REQUIREMENTS
16:2.0.1.5.118.0.2.1SECTION 1702.1
     1702.1 Purpose and policy.
16:2.0.1.5.118.0.2.2SECTION 1702.2
     1702.2 Procedural requirements and recommendations.
16:2.0.1.5.118.0.2.3SECTION 1702.3
     1702.3 Substantive requirements.
16:2.0.1.5.118.0.2.4SECTION 1702.4
     1702.4 Petitions with insufficient or incomplete information.
16:2.0.1.5.118.0.2.5SECTION 1702.5
     1702.5 Failure to supply adverse information.
16:2.0.1.5.118.0.2.6SECTION 1702.6
     1702.6 Trade secrets and other confidential information.
16:2.0.1.5.118.0.2.7SECTION 1702.7
     1702.7 Justification for the exemption.
16:2.0.1.5.118.0.2.8SECTION 1702.8
     1702.8 Human experience data.
16:2.0.1.5.118.0.2.9SECTION 1702.9
     1702.9 Relevant experimental data.
16:2.0.1.5.118.0.2.10SECTION 1702.10
     1702.10 Human experimental data involving the testing of human subjects.
16:2.0.1.5.118.0.2.11SECTION 1702.11
     1702.11 Product specifications.
16:2.0.1.5.118.0.2.12SECTION 1702.12
     1702.12 Packaging specifications.
16:2.0.1.5.118.0.2.13SECTION 1702.13
     1702.13 Labeling and packaging samples.
16:2.0.1.5.118.0.2.14SECTION 1702.14
     1702.14 Marketing history.
16:2.0.1.5.118.0.2.15SECTION 1702.15
     1702.15 Petitions alleging the incompatibility of child resistant packaging with the particular substance petitioned for exemption.
16:2.0.1.5.118.0.2.16SECTION 1702.16
     1702.16 Petitions requesting an exemption for a drug or a new drug.
16:2.0.1.5.118.0.2.17SECTION 1702.17
     1702.17 Granting petitions.
16:2.0.1.5.118.0.2.18SECTION 1702.18
     1702.18 Denying petitions.
16:2.0.1.5.118.0.2.19SECTION 1702.19
     1702.19 Effect of filing petition.